Cytotoxicity of liposomal α-tocopheryl succinate towards hamster cheek pouch carcinoma (HCPC-1) cells in culture

Cancer Letters

Volumn 239, Issue 2, 2006, Pages 281-291

  Gu, Xinbin ^a,b   Schwartz, Joel L ^c   Pang, Xiaowu ^a   Zhou, Yanfei ^b,d   Sirois, David A ^e   Sridhar, Rajagopalan ^b,d  

^a HOWARD UNIVERSITY   (United States)

^b HOWARD UNIVERSITY CANCER CENTER   (United States)

^c AMERICAN HEALTH FOUNDATION   (United States)

^d HOWARD UNIVERSITY HOSPITAL   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

Apoptosis; Cancer therapy; Ceramide; Ganglioside GD3; Vitamin E succinate

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; CERAMIDE; LIPOSOME; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOMA; CELL CULTURE; CELL VIABILITY; CHEEK POUCH; CONTROLLED STUDY; CYTOTOXICITY; HAMSTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANIMALS; APOPTOSIS; CHEEK; CRICETINAE; FLOW CYTOMETRY; IN SITU NICK-END LABELING; MOUTH NEOPLASMS; TUMOR CELLS, CULTURED; VITAMIN E;

CRICETINAE; TOSCANA VIRUS;

EID: 33745666251     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.08.028     Document Type: Article

References (40)

1. Tamano S., Fukushima S., Shirai T., Hirose M., and Ito N. Modification by alpha-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Lett 35 (1987) 39-46
2. Hirose M., Yada H., Hakoi K., Takahashi S., and Ito N. Modification of carcinogenesis by alpha-tocopherol, t-butylhydroquinone, propyl gallate and butylated hydroxytoluene in a rat multi-organ carcinogenesis model. Carcinogenesis 14 (1993) 2359-2364
3. Brigelius-Flohe R., Kelly F.J., Salonen J.T., Neuzil J., Zingg J.M., and Azzi A. The European perspective on vitamin E: current knowledge and future research. Am. J. Clin. Nutr. 76 (2002) 703-716
4. Anonymous. Prevention of cancer in the next millennium: report of the chemoprevention working group to the American Association for Cancer Research. Cancer Res 59 (1999) 4743-4758
5. Benner S.E., Winn R.J., Lippman S.M., Poland J., Hansen K.S., Luna M.A., and Hong W.K. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. J. Natl Cancer Inst. 85 (1993) 44-47
6. Sigounas G., Anagnostou A., and Steiner M. dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cells. Nutr. Cancer 28 (1997) 30-35
7. Papadimitrakopoulou V.A., Clayman G.L., Shin D.M., Myers J.N., Gillenwater A.M., Goepfert H., et al. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch. Otolaryngol. Head Neck Surg. 125 (1999) 1083-1089
8. Hong W.K. General keynote: the impact of cancer chemoprevention. Gynecol. Oncol. 88 (2003) S56-S58
9. Moyad M.A. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?. Urology 59 (2002) 9-19
10. Klein E.A. Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial. Recent Results Cancer Res. 163 (2003) 212-225
11. Yu W., Sanders B.G., and Kline K. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1. Nutr. Cancer 43 (2002) 227-236
12. Schwartz J.L., Gu X., Kittles R.A., Baptiste A., and Shklar G. Experimental oral carcinoma of the tongue and buccal mucosa: possible biologic markers linked to cancer at two anatomic sites. Oral Oncol. 36 (2000) 225-235
13. Weber T., Lu M., Andera L., Lahm H., Gellert N., Fariss M.W., et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (apo2 ligand) in vivo. Clin. Cancer Res. 8 (2002) 863-869
14. Yu W., Sanders B.G., and Kline K. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res. 63 (2003) 2483-2491
15. Neuzil J. Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br. J. Cancer 89 (2003) 1822-1826
16. Prasad K.N., Kumar B., Yan X.D., Hanson A.J., and Cole W.C. Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. J. Am. Coll. Nutr. 22 (2003) 108-117
17. Juliano R.L., Daoud S., Krause H.J., and Grant C.W. Membrane-to-membrane transfer of lipophilic drugs used against cancer or infectious disease. Ann. NY Acad. Sci. 507 (1987) 89-103
18. Thierry A.R., Vige D., Coughlin S.S., Belli J.A., Dritschilo A., and Rahman A. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes. Fed. Am. Soc. Exp. Biol. J 7 (1993) 572-579
19. Schwartz J.L., and Gu X. Hamster oral cancer model. In: Teicher B.A. (Ed). Tumor Models in Cancer Research (2001), Humana Press, Totowa, NJ 141-172
20. Neuzil J., Weber T., Schroder A., Lu M., Ostermann G., Gellert N., et al. Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements. Fed. Am. Soc. Exp. Biol. J 15 (2001) 403-415
21. Yu W., Sanders B.G., and Kline K. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Nutr. Cancer 27 (1997) 92-101
22. Qian M., Kralova J., Yu W., Bose H.R., Dvorak M., Sanders B.G., and Kline K. c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells. Oncogene 15 (1997) 223-230
23. Schwartz J.L. Nutrition and chemoprevention of head, neck and lung cancers. In: Heber D., Blackburn G.L., and Go V.L.W. (Eds). Nutrition Oncology (1999), Academic Press, New York 421-445
24. Niukian K., Schwartz J.L., and Shklar G. In vitro inhibitory effect of onion extract on hamster buccal pouch carcinogenesis. Nutr. Cancer 10 (1987) 137-144
25. Gorczyca W., Gong J., and Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53 (1993) 1945-1951
26. Oberhammer F.A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A.F., Bursch W., and Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. Natl Acad. Sci. USA 89 (1992) 5408-5412
27. Barak A., Morse L.S., and Goldkorn T. Ceramide: a potential mediator of apoptosis in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 42 (2001) 247-254
28. Bose R., Chen P., Loconti A., Grüllich C., Abrams J.M., and Kolesnick R.N. Ceramide generation by the Reaper protein is not blocked by the caspase Inhibitor, p35. J. Biol. Chem. 273 (1998) 28852-28859
29. Majczak A., Karbowski M., Kaminski M., Masaoka M., Kurono C., Niemczyk E., et al. Modification of physicochemical properties of actin filaments suppresses cell fragmentation in the execution phase of staurosporine-induced apoptotic processes. J. Electron Microsc. (Tokyo) 53 (2004) 635-647
30. Rabkin S.W., and Kong J.Y. Discordance between the effect of modulators of calcium on staurosporine-induced apoptosis and staurosporine-induced actin degradation. Cell Biol. Int. 26 (2002) 433-440
31. White S.R., Williams P., Wojcik K.R., Sun S., Hiemstra P.S., Rabe K.F., et al. Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 24 (2001) 282-294
32. Malisan F., and Testi R. GD3 ganglioside and apoptosis. Biochim. Biophys. Acta 1585 (2002) 179-187
33. Basu S., Ma R., Boyle P.J., Mikulla B., Bradley M., Smith B., et al. Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis-platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside. Glycoconj. J. 20 (2004) 563-577
34. Bektas M., and Spiegel S. Glycosphingolipids and cell death. Glycoconj. J. 20 (2004) 39-47
35. Morales A., Colell A., Mari M., Garcia-Ruiz C., and Fernandez-Checa J.C. Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj. J. 20 (2004) 579-588
36. Fernandez-Checa J.C. Redox regulation and signaling lipids in mitochondrial apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 471-479
37. Bhunia A.K., Schwarzmann G., and Chatterjee S. GD3 recruits reactive oxygen species to induce cell proliferation and apoptosis in human aortic smooth muscle cells. J. Biol. Chem. 277 (2002) 16396-16402
38. Copani A., Melchiorri D., Caricasole A., Martini F., Sale P., Carnevale R., et al. Beta -amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons. J. Neurosci. 22 (2002) 3963-3968
39. Neuzil J., Zhao M., Ostermann G., Sticha M., Gellert N., Weber C., et al. Alpha-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability. Biochem. J. 362 (2002) 709-715
40. Israel K., Yu W., Sanders B.G., and Kline K. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr. Cancer 36 (2000) 90-100